[Clotting factor concentrates].
Topics of this survey are the indications and use of plasma-derived and recombinant coagulation factor concentrates. These substitution therapies need to be handled carefully by weighing up their effectiveness against the long and short term side effects in the individual patient.
Barthels
M
M
Abteilung Hämatologie und Onkologie, Medizinische Hochschule Hannover, Germany.
Schramm
W
W
D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D006801:Humans
D001779:Blood Coagulation Factors